General aspects of the cellular response to low- and high-LET radiation, European Journal of Nuclear Medicine, vol.28, issue.4, pp.541-61, 2001. ,
DOI : 10.1007/s002590100484
: A Long-Term Study of Renal Function in Nude Mice, Cancer Biotherapy & Radiopharmaceuticals, vol.24, issue.6, pp.649-580628, 2009. ,
DOI : 10.1089/cbr.2009.0628
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody, Physics in Medicine and Biology, vol.56, issue.3, pp.721-330031, 2011. ,
DOI : 10.1088/0031-9155/56/3/012
URL : http://europepmc.org/articles/pmc3034478?pdf=render
Renal Tubulointerstitial Changes after Internal Irradiation with ??-Particle-Emitting Actinium Daughters, Journal of the American Society of Nephrology, vol.16, issue.9, pp.2677-89, 2005. ,
DOI : 10.1681/ASN.2004110945
URL : http://jasn.asnjournals.org/content/16/9/2677.full.pdf
Pharmacokinetics and toxicity of (213)Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer, Cancer Biol Ther, 2007. ,
DOI : 10.4161/cbt.6.6.4097
URL : http://www.tandfonline.com/doi/pdf/10.4161/cbt.6.6.4097?needAccess=true
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi-versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model, Cancer Res. Epub, vol.59, issue.110611, pp.2635-2678, 1999. ,
Alpha-versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi- AMBA versus 177Lu-DOTA-PESIN). Cancer Res, Feb, vol.1, issue.713, pp.1009-1027, 2011. ,
DOI : 10.1158/0008-5472.can-10-1186
URL : http://cancerres.aacrjournals.org/content/canres/71/3/1009.full.pdf
213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model. Clinical cancer research: an official journal of the American Association for Cancer Research, Feb, vol.1, issue.123, pp.897-903, 2006. ,
DOI : 10.1158/1078-0432.ccr-05-1264
URL : http://clincancerres.aacrjournals.org/content/clincanres/12/3/897.full.pdf
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis. European journal of nuclear medicine and molecular imaging, pp.602-614, 2012. ,
Radioimmunotherapy of micrometastases in lung with vascular targeted213Bi, British Journal of Cancer, vol.80, issue.1-2, pp.175-84, 1999. ,
DOI : 10.1038/sj.bjc.6690337
URL : http://www.nature.com/bjc/journal/v80/n1/pdf/6690337a.pdf
Biodistributions, myelosuppression , and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211. Cancer Res, Mar Epub, vol.15, issue.696, pp.2408-2423, 2009. ,
DOI : 10.1158/0008-5472.can-08-4363
URL : http://cancerres.aacrjournals.org/content/canres/69/6/2408.full.pdf
Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N?-tetraacetic acidbiotin . Clinical cancer research: an official journal of the American Association for Cancer Research, pp.3137-3183, 2004. ,
DOI : 10.1158/1078-0432.ccr-03-0171
URL : http://clincancerres.aacrjournals.org/content/clincanres/10/9/3137.full.pdf
Transport of macromolecules through microvascular walls. Cardiovascular research, pp.644-53, 1996. ,
DOI : 10.1016/s0008-6363(96)00064-8
URL : https://academic.oup.com/cardiovascres/article-pdf/32/4/644/735068/32-4-644.pdf
Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability, Journal of Angiogenesis Research, vol.2, issue.1, pp.142040-2384, 2010. ,
DOI : 10.1186/2040-2384-2-14
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies, Nuclear Medicine and Biology, vol.22, issue.3, 1995. ,
DOI : 10.1016/0969-8051(94)00126-5
Production of Ac-225 from Th-229 for targeted alpha therapy, Anal Chem. Oct, vol.1, issue.77, pp.6288-91, 2005. ,
DOI : 10.1021/ac0580114
213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma, Journal of Nuclear Medicine, vol.54, issue.9, pp.1597-604 ,
DOI : 10.2967/jnumed.112.111997
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril, Biochem Biophys Res Commun Feb Epub, vol.2828, issue.804, pp.849-57, 1978. ,
DOI : 10.1016/0006-291x(78)91322-0
Disposition of metals in rats: a comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals. Toxicology and applied pharmacology, pp.24-38, 1986. ,
Spatial Distribution of Blood Vessels and CD34+ Hematopoietic Stem and Progenitor Cells Within the Marrow Cavities of Human Cancellous Bone, Journal of Nuclear Medicine, vol.48, issue.4, pp.645-54, 2007. ,
DOI : 10.2967/jnumed.106.035337
Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System, Toxicologic Pathology, vol.115, issue.2, pp.5-81, 2010. ,
DOI : 10.1177/019262339502300409
URL : http://journals.sagepub.com/doi/pdf/10.1177/0192623310386499
Normal Tissue Tolerance Dose Metrics for Radiation Therapy of Major Organs, Seminars in Radiation Oncology, vol.17, issue.2, pp.131-4031, 2007. ,
DOI : 10.1016/j.semradonc.2006.11.009
Structure and Function of Bone Marrow Hemopoiesis: Mechanisms of Response to Ionizing Radiation Exposure, PMID: 12396705. Epub, pp.405-431, 2002. ,
DOI : 10.1089/108497802760363204
Changes with Age in Renal Function and Morphology in C57BL/6, CBA/HT6, and B6CBAF1 Mice, Journal of Gerontology, vol.37, issue.5, pp.540-547, 1982. ,
DOI : 10.1093/geronj/37.5.540
The impact of aging on kidney repair American journal of physiology Renal physiology, pp.1265-72, 2007. ,
Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts, Blood, vol.100, issue.1, pp.318-344, 2002. ,
DOI : 10.1182/blood-2001-12-0322
URL : http://www.bloodjournal.org/content/bloodjournal/100/1/318.full.pdf
Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation. Blood, Jun, vol.15, issue.10112, pp.5068-75, 2003. ,
DOI : 10.1182/blood-2002-12-3867
URL : http://www.bloodjournal.org/content/bloodjournal/101/12/5068.full.pdf
Targeted Alpha-Particle Immunotherapy for Acute Myeloid Leukemia, American Society of Clinical Oncology Educational Book, vol.34, issue.1004, pp.1233-1242, 2002. ,
DOI : 10.14694/EdBook_AM.2014.34.e126
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clinical cancer research: an official journal of the American Association for Cancer Research, pp.5303-5314, 2010. ,
DOI : 10.1158/1078-0432.ccr-10-0382
URL : http://clincancerres.aacrjournals.org/content/clincanres/16/21/5303.full.pdf
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia, J Nucl Med, vol.40, issue.11, pp.1935-1981, 1999. ,